Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans - Concepedia

Concepedia

Publication | Closed Access

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

138

Citations

11

References

2007

Year

Hsiao D. Lieu, John C. Shryock, Gregory O. von Mering, Toufigh Gordi, Brent Blackburn, Ann Olmsted, Luiz Belardinelli, Richard A. Kerensky

Journal of Nuclear Cardiology

ThrombosisCardiovascular DiseaseMedicinePhysiologyCardiovascular PharmacologyCardiologyVascular BiologyPharmacotherapyCardiovascular PhysiologyPharmacologyAtherosclerosisDose-dependent IncreasesCoronary Artery Disease

References

	Year	Citations

Page 1

Page 1